Skip to main content
Equibles

Driehaus Capital Management LLC

Position in LRMR — Larimar Therapeutics, Inc.

CIK 938206 Chicago, IL
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,648,440
-$3,556,355 QoQ
Shares Held
3,163,423
+7.8% QoQ
Ownership
3.05%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#5
of 162 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority Sole 85% Shared 0% None 15%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,707,249,767 across 60 Biotechnology names. LRMR ranks #46 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DFTX
Definium Therapeutics, Inc.
 6,845,276 $322,001,783
2 PRAX
Praxis Precision Medicines, Inc.
 959,048 $321,079,679
3 XENE
Xenon Pharmaceuticals Inc.
 4,418,557 $266,704,100
4 SYRE
Spyre Therapeutics, Inc.
 2,799,166 $248,509,957
5 CRNX
Crinetics Pharmaceuticals, Inc.
 6,463,551 $241,866,078
6 APGE
Apogee Therapeutics, Inc.
 1,740,101 $230,963,605
7 EWTX
Edgewise Therapeutics, Inc.
 4,728,623 $192,123,952
8 SEPN
Septerna, Inc.
 4,433,058 $148,463,112

All Filings in LRMR

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,648,440 3,163,423
2026-03-31 $13,204,795 2,934,399
2025-12-31 $2,040,117 535,464
2025-09-30 $1,729,548 535,464
2025-06-30 $1,547,490 535,464
2025-03-31 $765,389 355,995
2024-12-31 $4,914,342 1,269,856
2024-09-30 $8,378,026 1,279,088
2024-06-30 $9,527,268 1,314,106
2024-03-31 $8,259,642 1,088,227
2022-09-30 $381,513 119,223
2022-06-30 $412,580 210,500
2022-03-31 $852,525 210,500
2021-12-31 $2,271,295 210,500
2021-09-30 $2,427,065 210,500
2021-06-30 $2,067,110 210,500
2021-03-31 $3,075,405 210,500
2020-12-31 $2,365,805 110,500
2020-09-30 $1,289,450 85,000
2020-06-30 $1,092,250 85,000